1W Return
1M Return
6M Return
1Y Return
3Y Return
Start SIP in Vaishali Pharma
Vaishali Pharma Stock Performance
52 Week Low - High
Today’s Low - High
Open
Prev. Close
Total Traded Value
Vaishali Pharma Fundamental
Market Cap (in crs)
Face Value
Turnover (in lacs)
Key Metrics
Qtr Change %
45.93% Fall from 52W High
-16.9
Dividend yield 1yr %
0
Vaishali Pharma Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
Current Price
5Day EMA
13.70
10Day EMA
13.40
12Day EMA
13.30
20Day EMA
13.00
26Day EMA
13.00
50Day EMA
13.50
100Day EMA
14.60
200Day EMA
15.50
5Day SMA
14.10
10Day SMA
13.20
20Day SMA
12.60
30Day SMA
12.50
50Day SMA
13.30
100Day SMA
15.20
150Day SMA
16.30
200Day SMA
16.50
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 111925 Rs | 192918 Rs |
Week Rs | 483176 Rs | 1146104 Rs |
Month Rs | 358447 Rs | 881081 Rs |
Resistance & Support
13.93
Pivot
Resistance
First Resistance
14.26
Second Resistance
14.79
Third Resistance
15.12
Support
First Support
13.40
Second support
13.07
Third Support
12.54
Relative Strength Index
56.37
Money Flow Index
76.23
MACD
0.24
MACD Signal
-0.02
Average True Range
1.07
Average Directional Index
18.79
Rate of Change (21)
19.10
Rate of Change (125)
-26.36
Similar stocks
Similar Stocks
Peer comparison
Compare
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
147.07 | 10.3 | 24.91 | 13.72 | -8.86% | 7.07% | -25.46% | -15.02% | 48.51% | 0.00% | 343.00 | 40.76 | 2.25 | ||
164.62 | 78.06 | 157.98 | 103.40 | -8.27% | 21.75% | -15.72% | 3.13% | -10.16% | 1.16% | 15.88 | 40.76 | 1.54 | ||
Panchsheel Organics Ltd. | 142.05 | - | - | - | - | - | - | - | - | - | - | - | - | |
160.71 | 61 | 129.07 | 74.54 | -6.39% | 11.66% | -7.97% | 3.87% | -51.15% | 0.00% | 0.00 | 40.76 | -1.25 | ||
Auro Laboratories Ltd. | 247.70 | - | - | - | - | - | - | - | - | - | - | - | - | |
Syschem (India) Ltd. | 40.54 | - | - | - | - | - | - | - | - | - | - | - | - | |
Quest Laboratories Ltd. | 112.00 | - | - | - | - | - | - | - | - | - | - | - | - |
Vaishali Pharma Company background
Founded in: 2008
Managing director: Atul Vasani
Vaishali Pharma Limited was originally incorporated as a Private Limited Company with the name Vaishali Pharma Private Limited on 25th, April 2008. On July 01, 2008 the Company acquired the business of proprietorship concerns of its Promoter Mr. Atul Vasani viz. M/s. Vaishali Pharmachem through Business Assignment agreement. Consequently, the business of said Proprietorship Firm merged into Vaishali Pharma Private Limited. Subsequently, the Company converted into a Public Limited Company and the name was changed to Vaishali Pharma Limited on 21st, June 2017. Atul Vasani and Jagruti Vasani are the Promoters of the Company.Vaishali Pharma is a pharmaceutical company, dealing in pharmaceutical formulations, APIs, surgical products, veterinary supplements, herbal nutraceutical products. The Company is operating both in domestic and export markets. In domestic markets, it is majorly into trading of APIs whereas in export markets, it is into trading and marketing of APIs, formulations, surgical products and others. For the export markets, the Company gets the formulations whose facilities are approved and certified by respective countries for developing the products. The Company has over 250 + formulation brands marketed in multiple countries of which dossier is in CTD format along with itsrespective bioequivalence. The Company built a robust pipeline of around 250 Dossiers. The Companys synergistic collaboration with WHOGMP manufacturing facilities is backed by an excellent rapport with clients.In 2012, the Company ventured into new Vertical in Formulation Manufacturing and Exports. In 2016, it introduced a vertical of Surgical Division. The Company obtained ISO 9001:2015 Certification for the Quality Management System from Deutsche Accreditation Board, Germany and ISC Global, Dubai, UAE. It is also certified by European Certification Organisation and Compliance Certificate with regards to Council Directive relating to Surgical Instruments Medical Devices Directive. In addition, the Company has also been recognized by Government of India as One Star Export House and holds a valid certificate for the same from the Director General of Foreign Trade in 2017. In August 2017, Company came up with an Initial Public Offer consisting of Fresh Issue of 19,76,000 Equity Shares by raising capital aggregating Rs 14.22 Crore.
Vaishali Pharma FAQs
How has Vaishali Pharma shares performed in the past ?
Vaishali Pharma share price in the past 1-year return was -15.01. The Vaishali Pharma share hit a 1-year low of Rs. 10.3 and a 1-year high of Rs. 24.91.
What is the market cap of Vaishali Pharma ?
The market cap of Vaishali Pharma is Rs. 147.07 Cr. as of 30/4/2025.
What is the current P/E ratio of Vaishali Pharma ?
The PE ratios of Vaishali Pharma is 343 as of 30/4/2025.
What is the current PB ratio of Vaishali Pharma ?
The PB ratios of Vaishali Pharma is 2.24 as of 30/4/2025
How to buy Vaishali Pharma shares?
You can easily buy Vaishali Pharma shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Please be aware that Vaishali Pharma stock prices are subject to continuous fluctuations due to various factors.
Open Demat Account
